Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cirrhosis Advanced”

135 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 135 results

Post-approval studies (Phase 4)UnknownNCT03798119
What this trial is testing

TAF Switch in F3/4 CHB pt With Partial Response to NUC (ESTAB-AFPVR)

Who this might be right for
Hepatitis BFibrosis and Cirrhosis of Liver
Kaohsiung Medical University Chung-Ho Memorial Hospital 80
Not applicableStudy completedNCT01874249
What this trial is testing

Non Invasive Assessment of Liver Fibrosis in Fatty Liver Disease

Who this might be right for
Non Alcoholic Fatty Liver Disease
Fundación Clínica Médica Sur 1,200
Not applicableLooking for participantsNCT03472157
What this trial is testing

Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese Patients

Who this might be right for
SurgeryObesityNASH - Nonalcoholic Steatohepatitis+1 more
University Hospital, Lille 100
Testing effectiveness (Phase 2)Study completedNCT03420768
What this trial is testing

Experimental Medication BMS-986263 in Adults With Advanced Hepatic Fibrosis After Cure of Hepatitis C

Who this might be right for
Hepatic CirrhosisLiver Fibrosis
Bristol-Myers Squibb 61
Not applicableStudy completedNCT04173520
What this trial is testing

ELRIAH Score: A Simple Score for HCC Risk Stratification in CHC Patients With Cirrhosis or Advanced Liver Fibrosis Who Achieved SVR Following DAA Therapy

Who this might be right for
HCC
Egyptian Liver Hospital 2,326
Large-scale testing (Phase 3)WithdrawnNCT02837939
What this trial is testing

Transfer Factor Efficacy in the Management of Cirrhosis-associated Immune Dysfunction

Who this might be right for
CirrhosisLiver Failure
Martin Janičko
Testing effectiveness (Phase 2)Looking for participantsNCT06852287
What this trial is testing

Phase II Clinical Study of GemOX Hepatic Arterial Infusion Combined with Lenvatinib and Toripalimab for Advanced and Unresectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Gall Bladder Cancer
Tianjin Medical University Cancer Institute and Hospital 33
Not applicableStudy completedNCT04462874
What this trial is testing

Mean Systemic Filling Pressure Trends in Liver Transplant Recipients

Who this might be right for
Liver Transplant; ComplicationsLiver DiseasesHemodynamic Instability
Institute of Liver and Biliary Sciences, India 20
Testing effectiveness (Phase 2)Ended earlyNCT01079767
What this trial is testing

Temsirolimus in Treating Patients With Advanced Liver Cancer and Cirrhosis

Who this might be right for
Liver Cancer
Federation Francophone de Cancerologie Digestive 6
Not applicableUnknownNCT04975477
What this trial is testing

CHESS-SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102)

Who this might be right for
Compensated Advanced Chronic Liver Disease
Hepatopancreatobiliary Surgery Institute of Gansu Province 1,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07042919
What this trial is testing

Zanzalintinib in Second Line and Beyond for the Treatment of Advanced Liver Cancer

Who this might be right for
Advanced Hepatocellular CarcinomaCirrhosisStage III Hepatocellular Carcinoma AJCC v8+1 more
Northwestern University 53
Not applicableNot Yet RecruitingNCT07305324
What this trial is testing

Improving Liver Fibrosis Diagnosis in Primary Care Using FibroX AI

Who this might be right for
MASLDFibrosis of Liver
Yale University 40
Not applicableUnknownNCT03933891
What this trial is testing

Magnetic Resonance Technics for the Assessment of Liver Function Before and After TIPS

Who this might be right for
Liver CirrhosisTransjugular Intrahepatic Portosystemic Shunt (TIPS)Functional Magnetic Resonance Imaging
West China Hospital 200
Early research (Phase 1)Study completedNCT06974565
What this trial is testing

Investigate the Pharmacokinetics of AZD2389 in Healthy Participants When Administered Alone and in Combination With Quinidine

Who this might be right for
Advanced Chronic Liver DiseaseHealthy Participants
AstraZeneca 16
Testing effectiveness (Phase 2)Active Not RecruitingNCT06777316
What this trial is testing

An FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)CholangiocarcinomaOther Solid Tumors, Adult+9 more
Cogent Biosciences, Inc. 110
Early research (Phase 1)Study completedNCT01289951
What this trial is testing

Pharmacokinetic Study of Raltegravir in Human Immunodeficiency Virus/Hepatitis C Virus (HIV/VHC) Coinfected Patients With Advanced (Child-Pugh C) Hepatic Cirrhosis

Who this might be right for
Human Immunodeficiency VirusHepatitis C
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal 10
Post-approval studies (Phase 4)Study completedNCT00179413
What this trial is testing

Study of Long-term Peg Intron vs. Colchicine in Non-responders.

Who this might be right for
Hepatitis C VirusAdvanced FibrosisCirrhosis
Beth Israel Deaconess Medical Center 549
Not applicableStudy completedNCT04384159
What this trial is testing

Combination Diagnostic Strategies in NAFLD

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseChronic Liver Disease
University Hospital, Montpellier 577
Not applicableNot Yet RecruitingNCT07208526
What this trial is testing

Trial of Surgical Decision-Making Guided by TDTP-RECIST

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Conversion TherapyTDTP-RECIST+1 more
Shanghai Zhongshan Hospital 270
Testing effectiveness (Phase 2)Looking for participantsNCT05832229
What this trial is testing

Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States

Who this might be right for
CirrhosisCirrhosis, LiverCirrhosis Early+5 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 256
Load More Results